Sensei Biotherapeutics Stock In The News

SNSE Stock  USD 0.53  0.07  11.67%   
Our overall analysis of Sensei Biotherapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Sensei Biotherapeutics. The specific impact of Sensei Biotherapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Sensei Biotherapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Sensei Biotherapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Sensei Biotherapeutics Backtesting and Sensei Biotherapeutics Hype Analysis.
For information on how to trade Sensei Stock refer to our How to Trade Sensei Stock guide.

Sensei Biotherapeutics Today Top News and Investor Outlook

Yahoo News
Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones
https://finance.yahoo.com/news/sensei-biotherapeutics-provides-corporate-highlights-123000793.html
 Neutral
Yahoo News
Sensei Biotherapeutics Inc (SNSE) Reports Q3 2023 Financial Results
https://finance.yahoo.com/news/sensei-biotherapeutics-inc-snse-reports-130904269.html
 Neutral
Macroaxis News: globenewswire.com
Sensei Biotherapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
https://www.globenewswire.com/news-release/2023/11/07/2774982/0/en/Sensei-Biotherapeutics-Reports-Third-Quarter-2023-Financial-Results-and-Recent-Business-Highlights.html
 Neutral
Yahoo News
Sensei Biotherapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
https://finance.yahoo.com/news/sensei-biotherapeutics-reports-third-quarter-123000113.html
 Neutral
Macroaxis News: globenewswire.com
Sensei Biotherapeutics Reports Favorable Clinical Data for SNS-101 at 2023 SITC Annual Meeting
https://www.globenewswire.com/news-release/2023/11/03/2773437/0/en/Sensei-Biotherapeutics-Reports-Favorable-Clinical-Data-for-SNS-101-at-2023-SITC-Annual-Meeting.html
 Neutral
Yahoo News
Sensei Biotherapeutics Reports Favorable Clinical Data for SNS-101 at 2023 SITC Annual Meeting
https://finance.yahoo.com/news/sensei-biotherapeutics-reports-favorable-clinical-200500820.html
 Neutral
Macroaxis News: globenewswire.com
Sensei Biotherapeutics Appoints Stephanie Krebs, MS, MBA, as Chief Business Officer
https://www.globenewswire.com/news-release/2023/11/01/2771019/0/en/Sensei-Biotherapeutics-Appoints-Stephanie-Krebs-MS-MBA-as-Chief-Business-Officer.html
 Neutral
Yahoo News
Sensei Biotherapeutics Appoints Stephanie Krebs, MS, MBA, as Chief Business Officer
https://finance.yahoo.com/news/sensei-biotherapeutics-appoints-stephanie-krebs-113000170.html
 Neutral
Macroaxis News: globenewswire.com
Sensei Biotherapeutics to Present Initial Clinical Data from Dose Escalation Trial of SNS-101 at 2023 SITC Annual Meeting
https://www.globenewswire.com/news-release/2023/10/25/2766615/0/en/Sensei-Biotherapeutics-to-Present-Initial-Clinical-Data-from-Dose-Escalation-Trial-of-SNS-101-at-2023-SITC-Annual-Meeting.html
 Neutral
Yahoo News
Sensei Biotherapeutics to Present Initial Clinical Data from Dose Escalation Trial of SNS-101 at 2023 SITC Annual Meeting
https://finance.yahoo.com/news/sensei-biotherapeutics-present-initial-clinical-130500656.html
 Neutral

Sensei Biotherapeutics Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Sensei and other traded companies coverage with news coverage. We help investors stay connected with Sensei headlines for the 26th of November to make an informed investment decision based on correlating the impacts of news items on Sensei Stock performance. Please note that trading solely based on the Sensei Biotherapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Sensei Biotherapeutics' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Sensei Biotherapeutics investors visualize upcoming and past events in order to time the market based on Sensei Biotherapeutics noise-free hype analysis.
Sensei Biotherapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Sensei earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Sensei Biotherapeutics that are available to investors today. That information is available publicly through Sensei media outlets and privately through word of mouth or via Sensei internal channels. However, regardless of the origin, that massive amount of Sensei data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Sensei Biotherapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Sensei Biotherapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Sensei Biotherapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Sensei Biotherapeutics alpha.

Sensei Largest EPS Surprises

Earnings surprises can significantly impact Sensei Biotherapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-08-04
2021-06-30-0.29-0.32-0.0310 
2024-05-09
2024-03-31-0.28-0.32-0.0414 
2022-03-10
2021-12-31-0.34-0.30.0411 
2022-08-09
2022-06-30-0.39-0.340.0512 
2022-05-10
2022-03-31-0.35-0.4-0.0514 
2023-11-07
2023-09-30-0.34-0.280.0617 
View All Earnings Estimates

Sensei Biotherapeutics Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Sensei Biotherapeutics Stock. Current markets are strongly bearish. About 75% of major world exchanges and indexes are down. See today's market update for more information.
Google News at Macroaxis
18th of November 2024
Sensei Biotherapeutics Q3 2024 Results and Strategic Moves - TipRanks
at news.google.com 
Google News at Macroaxis
29th of October 2024
Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences - StockTitan
at news.google.com 
Macroaxis News
18th of October 2024
Acquisition by Ricks Thomas G of 14550 shares of Sensei Biotherapeutics at 1.22 subject to...
at MacroaxisInsider 
Google News at Macroaxis
12th of September 2024
Sensei Biotherapeutics stock hits 52-week low at 0.51 - Investing.com
at news.google.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sensei Biotherapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sensei Biotherapeutics' short interest history, or implied volatility extrapolated from Sensei Biotherapeutics options trading.
When determining whether Sensei Biotherapeutics is a strong investment it is important to analyze Sensei Biotherapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sensei Biotherapeutics' future performance. For an informed investment choice regarding Sensei Stock, refer to the following important reports:
Check out Sensei Biotherapeutics Backtesting and Sensei Biotherapeutics Hype Analysis.
For information on how to trade Sensei Stock refer to our How to Trade Sensei Stock guide.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sensei Biotherapeutics. If investors know Sensei will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sensei Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.19)
Return On Assets
(0.27)
Return On Equity
(0.45)
The market value of Sensei Biotherapeutics is measured differently than its book value, which is the value of Sensei that is recorded on the company's balance sheet. Investors also form their own opinion of Sensei Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sensei Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sensei Biotherapeutics' market value can be influenced by many factors that don't directly affect Sensei Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sensei Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sensei Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sensei Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.